Skip to main content

Use of 123-I Radiolabelled F(AB’)2 Fragments of Anti-CEA Monoclonal Antibody for the Detection of Primary and Metastatic Gastrointestinal Carcinomas

  • Chapter
Clinical Use of Antibodies

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 19))

  • 35 Accesses

Summary

F(ab’)2 fragments of an anti-CEA monoclonal antibody were radiolabelled with 123-I and used to study eleven patients with various types of gastrointestinal carcinomas. The antibody scans detected primary or metastatic disease in 4 out of 7 patients with known disease and they suggested the existence of disease in 3 cases, in sites not detected by conventional techniques. In 1 patient, liver metastases were detected with the antibody scan 3 months earlier than with CT scan examination. Absence of disease was confirmed in 3 patients in complete remission. These results indicate that external scintigraphy using 123-I labelled F(ab’)2 fragments of anti-CEA monoclonal antibodies may be a useful tool in monitoring patients with gastrointestinal tumours in terms of confirming the results of conventional methods or revealing disease sites undetected by conventional radiology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Begent R.H.K. et al (1980) Radioimmunolocalisationof tumours by external scintigraphy after administration of 131-I antibody to human chronic gonadotropin: preliminary communication. J. Royl. Soc. Med. 73: 624–630

    CAS  Google Scholar 

  2. Berche C. et al(1982) Tomoscintigraphyfor detecting gastrointestinaland medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcino embryonic antigen. Br. Med. J. 285: 1447–1451

    Article  CAS  Google Scholar 

  3. Chatal J.F. et al (1984) Immunoscintigraphyof colon carcinoma. J. Nucl. Med. 25: 307–314

    PubMed  CAS  Google Scholar 

  4. Dykes D.W. et al (1980) Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonicantigen Br.Med.J. 280: 220–222

    Article  PubMed  CAS  Google Scholar 

  5. Delaloye B. et al (1985) First approach to therapy of liver metastases in colorectal carcinoma by intrahepatically infused 131-I labelled monoclonal anti-CEA antibodies. Eur. J. Nucl. Med. 11:A37

    Article  Google Scholar 

  6. Delaloye B et al (1986) Detection of colorectal carcinoma by emission computerised tomography after injection of 123-I labelled Fab and F(ab’)2 fragments from monoclonal anti-carcinoembryonicantigen antibodies. J.Clin.Inv. 77: 301–311

    Article  CAS  Google Scholar 

  7. Endo T. et al (1985) Immunohistologic distribution of CEA defined by human anti-CEA antibody in the serum of a colonic cancer patient. Cancer 56: 2205–2211

    Article  PubMed  CAS  Google Scholar 

  8. Epenetos A.A, et al (1984) Antibody guided irradiationof malignant lesions. Lancet 1: 1441–1443

    Google Scholar 

  9. Fritzberg AR. et al (1988) Specific and stable labelling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. USA 85: 4025–4029

    Article  PubMed  CAS  Google Scholar 

  10. Goldenberg D. et al (1978) Use of radiolabelled antibodies to carcinoembryonic antigen for the detection and localisation of diverse cancers by external photoscanning. New Engl. J. Med. 298: 1384–1388

    Article  PubMed  CAS  Google Scholar 

  11. Kalofonos H.P. et al (1988) Kinetics, quantitativeanalysis and radioimmunolocalisationusing indium-111HMFG1 monoclonal antibody in patients with breast cancer. Br. J. Cancer 59: 934–942

    Google Scholar 

  12. Kohler G and Milstein C (1975) Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256: 465–467

    Article  Google Scholar 

  13. Mach J.P et al (1980) Tumour localisation of radiolabelled antibodies against carcinoembryonic antigen in patients with carcinoma. New Engl. J. Med. 305: 5–10

    Article  Google Scholar 

  14. Mach J.P. et al (1981) Use of 131-I radiolabelled monoclonal anti-CEA antibodies for the detectionof human carcinomas by external photoscanningand tomoscintigraphy. Immunology Today 2: 239–249

    Article  Google Scholar 

  15. Pectasides D. et al (1986) Antibody guided irradiation of malignant pleural and pericardial effusions. Br. J. Cancer 53: 727–732

    Article  PubMed  CAS  Google Scholar 

  16. Reay P. (1982) Use of N-bromosuccinimide for the iodination of proteins for radioimmunoassay. Ann. Clin. Biochem. 19: 129–133

    PubMed  CAS  Google Scholar 

  17. Riva P et al (1988) Antibody-guided diagnosis an Italian experience on CEA-expressing tumours In. J. Cancer Supplement 2: 114–120

    CAS  Google Scholar 

  18. Siccardi A.G. et al (1989) Immunoscintigraphy of adenocarcinomas by means of radiolabelled F(ab’)2 fragments of an anti-carcinoembryonicantigen monoclonal antibody: a multicentre study. Cancer Res. 49: 3095–3103.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Bamias, A. et al. (1991). Use of 123-I Radiolabelled F(AB’)2 Fragments of Anti-CEA Monoclonal Antibody for the Detection of Primary and Metastatic Gastrointestinal Carcinomas. In: Baum, R.P., Cox, P.H., Hör, G., Buraggi, G.L. (eds) Clinical Use of Antibodies. Developments in Nuclear Medicine, vol 19. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3516-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3516-0_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5555-0

  • Online ISBN: 978-94-011-3516-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics